NEW YORK (GenomeWeb) – George Mason University's Center for Applied Proteomics and Molecular Medicine has obtained accreditation from the Commission on Laboratory Accreditation of the College of American Pathologists.
According to Lance Liotta, co-chair of the center and the laboratory's medical director, the accreditation will help the facility more quickly move findings from its clinical trials into clinical use.
The accreditation will also ease submission and sharing of clinical data, noted Virginia Espina, research associate professor at the center.
"Work done under the auspices of CAP accreditation can be submitted to other regulatory agencies, such as the [US] Food and Drug Administration, without the need for re-testing, and we can perform clinical research trials with human subjects for pharmaceutical companies or other sponsors," she said in a statement.
CAP accreditation involves examination of a laboratory’s records and quality control procedures for the preceding two years as well as examination of staff qualifications, laboratory equipment, safety programs and records, and overall laboratory management.